Peira, Exmore life sciences

Market and technology: Pre-Clinical imaging/research tools.
Key responsibilities: Worldwide business development, product strategy.

Peira,, the life sciences division of the Exmore Group,, developed an innovative tool to measure tumor volumes of xenografts in mice, the TM900, Researchers commonly measure width and length using a caliper and calculate the volume by a standard formula. The TM900, using stereo imaging and surface reconstruction, makes a direct 3D volume measurement. Budetec has an exclusive agreement for worldwide business development and sales for the instrument. It currently is the main activity for Budetec.

Advionics ( ex. EADS, Airbus) Oostkamp

Market and technology: Aerospace en defense, production of HF / RF radio, radar en satellite communication equipment.
Key responsibilities: Business Development, sales and commercial strategy.

Advionics, , in Oostkamp was a subsidiary, production plant, of Cassidian, a division of Airbus/EADS. Until 2013 the plant only produced for Cassidian and had a passive business development model. Orders came from, or projects were delegated by, its headquarters in Germany. Turnover was generated only by internal productions for Cassidian and/or Airbus / EADS. Changes in the defense market and reduction in military spending generated a need for new business and customers. Hence the plant in Oostkamp opened its know-how and infrastructure for third parties. This required a new and more active business development and sales strategy, my role is its planning, initiation and roll-out. I am involved at director level.


Market and technology: Test and measurement systems for materials science in Nano technology, main customers, research and development in industry and academic, in sectors such as semiconductor, medical et… .
Key responsibilities: Business development, sales and management.

Nanovea,, started its activities in 2006. They were a new player in the market of Nano- and micro hardness and scratch testing with applications in material investigation for various industries such as semiconductor, medical appliances, automotive, etc… . Erik initiated the European business development and sales activities. Main responsibilities and results were:
      – Introduction of the Nanovea products on the European market. (Nanovea has strong European competition from long established German and Swiss manufacturers)
      – Direct customer contacts and sales in Benelux, Scandinavia and Germany.
      – Establish partnerships with distributers in East and South Europe.

UZ-VUB University Hospital, Brussels.

Market and technology: Hospital management, health care, software platform.
Key responsibilities: Business development, sales.

The information technology department from the Hospital has developed a flexible and powerful software platform and environment supporting the admiration of the hospital and health care processes. There was a big interest from other hospitals to implement it in their organizations. My assignment was the investigation of a potential spin-off and valorization, commercialization towards third parties. I was involved in the commercial discussions. The result was a first contract in the order of magnitude, 3.000.000 Euros. www.UZ VUB tech